Financials
Financial year 2025
NOVICREO from Fernelmont, company number BE0885428866, closed financial year 2025 with a result of € 115,461 after tax. For that financial year NOVICREO recorded a gross margin of € 154,907 and equity of € 519,259. Compared with financial year 2024, the result moved from € 284,572 to € 115,461. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 1, 2026.
€ 519,259
▲ 13% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 115,461
▼ 59% vs 2024
Profit after tax over the fiscal year.
€ 47,688
▼ 53% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 55,000 paid out
48 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
€ 78,048
▲ 247% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 2,210
▲ 146% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 85,411
▲ 52% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 84,958 | € -6,628 | € 419,238 | € 154,907 | ▼ 63% |
| Profit after taxes | € 51,801 | € -3,320 | € 284,572 | € 115,461 | ▼ 59% |
| Equity | € 237,547 | € 214,226 | € 458,798 | € 519,259 | ▲ 13% |
| Total debts | € 51,260 | € 17,405 | € 99,390 | € 88,861 | ▼ 11% |
| Cash | € 136,916 | € 29,763 | € 100,427 | € 47,688 | ▼ 53% |
| Land & buildings | € 8,932 | € 4,574 | - | - | |
| Retained profit | € 217,547 | € 192,226 | € 436,798 | € 497,259 | ▲ 14% |
| Dividend | € 0 | € 20,000 | € 40,000 | € 55,000 | ▲ 38% |
| Bank debt | € 0 | € 0 | € 13 | € 0 | ▼ 100% |
| Balance sheet total | € 288,807 | € 231,631 | € 558,188 | € 608,120 | ▲ 9% |
Key figures of NOVICREO, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to NOVICREO?
What happened at NOVICREO in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 115,461 (▼ 59% vs 2024). Source: NBB ↗
- New establishment in Fernelmont. KBO
- DOMINIQUE DEMOLLE became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 51,801 profit in 2022 to € 115,461 profit in 2025.
Paid € 185,462 in corporate taxes since 2022.
Best year ever: 2024, with € 284,572 profit.
Paid out € 115,000 in dividends to the owners in total.
Management
Behind NOVICREO is DOMINIQUE DEMOLLE. It owns 2.6% of TOOLS4PATIENT itself.
Directors
According to the 2025 annual accounts
since 2007
Establishments
Establishment units
Physical locations of this company
Rue de Hanret, C.-W. 14
5380 Fernelmont
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0885.428.866
- VAT number
- BE 0885.428.866
- Registered office
- Rue de Hanret, C.-W. 14, 5380 Fernelmont
- Names & denominations
- NOVICREO
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 22 November 2006
- Peppol
- Active · Active since 4 Dec 2025
- Activities · NACE
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Overige vormen van onderwijs
Catering van evenementen
Activiteiten op het gebied van computerconsultancy en beheer van computerfaciliteiten
Uitzendkoks en verzorgen van feesten en recepties
Computeradviesbureaus
+2